Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

IDT Expanding Vaccine Capacity

September 21, 2010 8:53 am | News | Comments

IDT Biologika GmbH, a global integrated contract manufacturer of vaccines and biopharmaceuticals, introduced plans to expand its viral vaccine production capacity with the addition of a new high-speed filling line and additional lyophilisation capacity.

TOPICS:

FDA Panel Backs VIVITROL For Opioid Addiction

September 21, 2010 8:50 am | News | Comments

Alkermes, Inc. announced that the U.S. Food and Drug Administration Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL should be approved for the treatment of opioid dependence.

TOPICS:

Structural Molecule Worsens Pneumonia

September 21, 2010 8:42 am | News | Comments

A structural molecule and the cellular pump that regulates its levels influence the severity of pneumonia and could provide new ways of treating the lung infection, which is a leading cause of hospitalization and death.

TOPICS:
Advertisement

Marijauna-Like Chemical Controls Pain from Injury

September 21, 2010 8:40 am | News | Comments

American and Italian researchers have found that a novel drug allows anandamide – a marijuana-like chemical in the body – to effectively control pain at the site of an injury.

TOPICS:

New Pathway Regulates Immune Balance

September 21, 2010 8:27 am | News | Comments

St. Jude Children's Research Hospital scientists have identified a new pathway that helps control the immune balance through reciprocal regulation of specialized T lymphocytes, which play very different inflammatory roles.

TOPICS:

Preclinical Data Shows MultiStem Benefits

September 21, 2010 7:56 am | News | Comments

Athersys, Inc. announced the publication of a key study demonstrating that intravenous injection of MultiStem, Athersys' multipotent adult progenitor stem cell therapy product, provides neurovascular protection after traumatic brain injury.

TOPICS:

PTC Recieves Orphan Drug Grant from FDA

September 21, 2010 7:45 am | News | Comments

PTC Therapeutics, Inc. announced a grant award of approximately $1.6 million from the FDA Office of Orphan Products Development to support an ongoing Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis.

TOPICS:

Advanced Clinical Improves Trials With Codified Delivery

September 21, 2010 7:27 am | News | Comments

Advanced Clinical, a leading provider of clinical research services, is accelerating clinical trials through codified delivery methodologies, tools and techniques.

TOPICS:
Advertisement

Almac Facility Passes First Inspection

September 21, 2010 7:02 am | News | Comments

Almac’s Clinical Technologies division announced that it had successfully passed one of the UK’s first joint routine GCP/GMP Medicines and Healthcare Products Regulatory Agency inspections at its Craigavon, UK site.

TOPICS:

Mylan Producing Generic Prograf

September 21, 2010 6:47 am | News | Comments

The drugmaker Mylan Inc. said it received Food and Drug Administration approval for a generic version of the Astellas Pharma drug Prograf, which is used to prevent rejection of transplanted organs.

TOPICS:

Three Lasker Awards Given Out

September 21, 2010 6:46 am | by Malcolm Ritter | News | Comments

Three scientists have won prestigious medical prizes - one for devising a treatment for a major cause of vision loss and two for laying the groundwork for an explosion in obesity research.

TOPICS:

Brain Tangles Offer Alzheimer's Clue

September 21, 2010 6:43 am | by Lauran Neergaard | News | Comments

That sticky gunk coating Alzheimer's patients' brains gets all the notoriety, but another culprit is gaining renewed attention: Protein tangles that clog brain cells and just might determine how fast patients go downhill.

TOPICS:

FDA Extends Avastin Review Til December

September 21, 2010 6:40 am | News | Comments

Drugmaker Roche said that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.

TOPICS:

FDA Gives Go-Ahead to New Medtronic Stent

September 21, 2010 5:55 am | News | Comments

Medtronic Inc., the world's largest medical device maker, said it has received U.S. approval for a new artery-bracing stent that may be easier for surgeons to implant.

TOPICS:

Sanofi Diabetes Drug Effective

September 21, 2010 5:50 am | News | Comments

Sanofi-Aventis said that a study of its experimental diabetes drug showed better blood sugar control than placebo. The study included 361 patients with type 2 diabetes who randomly received either lixisenatide, the company's diabetes injectable, or a sham treatment.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading